In a recent presentation at Hoag Memorial Hospital in Newport Beach, California, Dr. Christopher Duma addressed the ongoing challenges in treating neuro-degenerative diseases such as Parkinson’s, Alzheimer’s, and dementia, noting the continued lack of effective therapies.

He then presented encouraging pre-clinical results from Regeneration Biomedical’s patented technology, which uses a patient’s own treated stem cells delivered metronomically through an implanted drug reservoir directly into affected areas of the brain.

The promising outcomes mark a significant step forward as the company prepares to submit the data to the FDA in pursuit of additional human clinical trials